[go: up one dir, main page]

WO2018190479A1 - Method for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial - Google Patents

Method for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial Download PDF

Info

Publication number
WO2018190479A1
WO2018190479A1 PCT/KR2017/012104 KR2017012104W WO2018190479A1 WO 2018190479 A1 WO2018190479 A1 WO 2018190479A1 KR 2017012104 W KR2017012104 W KR 2017012104W WO 2018190479 A1 WO2018190479 A1 WO 2018190479A1
Authority
WO
WIPO (PCT)
Prior art keywords
clinical trial
volunteer
information
clinical
medical institution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2017/012104
Other languages
French (fr)
Korean (ko)
Inventor
이병일
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hba Co ltd
Original Assignee
Hba Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020170086257A external-priority patent/KR20180133301A/en
Application filed by Hba Co ltd filed Critical Hba Co ltd
Publication of WO2018190479A1 publication Critical patent/WO2018190479A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires

Definitions

  • the present invention relates to a clinical trial information matching technology, and more particularly, to a method for matching clinical trial information between a clinical trial volunteer and a clinical research institute or a research institute.
  • the present invention has been made to solve the above-mentioned problems of the prior art, collects the clinical trial volunteer recruitment provided from the clinical institution in charge of the investigation online, and the basic digital questionnaire information and clinical trial volunteer questionnaire information required for the clinical trial
  • the task is to provide a method for matching clinical trial information between clinical trial volunteers and clinical research institutes that can be digitally matched and screened and filtered eligible or ineligible subjects.
  • an embodiment of the present invention is to receive and install the clinical trial support app from the clinical trial information integrated server to the clinical trial volunteer terminal and the clinical trial information integrated server, from the clinical trial volunteer terminal Receiving and storing basic personal and physical information of a clinical trial volunteer; searching and collecting the clinical trial volunteer recruitment notice announced by the clinical research institute; and classifying the collected clinical trial volunteer recruitment notice. And generating and storing the basic digital questionnaire corresponding to the clinical trial volunteer recruitment information, and providing the clinical trial volunteer recruitment announcement and the basic digital questionnaire to the clinical trial volunteer terminal.
  • the basic digital provided to the test volunteer terminal Generating a clinical trial volunteer questionnaire according to the information inputted from the questionnaire and transmitted from the clinical trial volunteer terminal, and comparing the basic digital questionnaire information and the clinical trial volunteer questionnaire information to determine eligibility or ineligibility of the clinical trial subject Between the clinical trial volunteer and the clinical trial management institution, comprising: informing the clinical volunteer volunteer terminal whether the clinical trial candidate is eligible or ineligible; and providing the clinical trial volunteer questionnaire information to the primary clinical research institute. Provide clinical information matching method.
  • the collected clinical trial volunteer recruitment notification may be classified by disease name, medical department, body part, and region to generate the clinical trial volunteer recruitment information.
  • the method may further include generating an additional digital questionnaire requested by the clinical trial management institution and providing it to the qualified volunteer terminal.
  • said additional digital questionnaire may comprise a short answer questionnaire.
  • the method may further include transmitting the interview request information requested from the clinical trial management institution to the qualified volunteer terminal.
  • the method may further include translating and providing a domestic clinical trial information provided in a foreign language to a foreign clinical trial information site in a Korean language.
  • the clinical trial volunteer questionnaire may be analyzed to further filter the clinical trial overlap support within a specific period of time to further determine the eligibility or ineligibility of the clinical trial subject.
  • the method may further include the step of receiving registration and management of clinical trial subject medical institution information and clinical trial volunteer recruitment information from the clinical trial subject medical institution.
  • the trial volunteer information for the specific clinical trial is first received and stored from the clinical trial volunteer terminal, and subsequently, the clinical trial administration
  • the clinical trial volunteer recruitment notice for the specific clinical trial is registered from a medical institution
  • the clinical trial volunteer recruitment notification is notified to the clinical trial volunteer terminal, and the clinical trial volunteer information received in advance transmits the specific clinical trial registration notification. It may include a period of validity information, and further comprising the step of notifying the clinical volunteer volunteer terminal whether the extension of the validity of the specific clinical trial registration notification at the end of the validity period and to stop or extend the registration notification for this; have.
  • the present invention by collecting the clinical trial volunteer recruitment announcement announced by the pharmaceutical company, each medical organization, medical institution or clinical trial conducting institution to digitally match the basic digital questionnaire information required for the clinical trial and the corresponding clinical trial volunteer questionnaire information Afterwards, the most appropriate clinical trial volunteers for the clinical trial can be easily selected as qualified and ineligible candidates, and among the qualified persons, the overlapping clinical trial volunteers are filtered within a specific period of time, and the personnel involved in the recruitment of clinical trial volunteers and the clinical trial process. And by reducing the cost significantly, there is an effect that can contribute to the health promotion of the clinical trial volunteers.
  • 1A is a schematic flowchart of a method for matching clinical trial information between a clinical trial volunteer and a clinical trial supervising medical institution according to a preferred embodiment of the present invention.
  • FIG. 1B is a schematic flowchart of an unregistered clinical trial processing step of the clinical trial information matching method of FIG. 1A.
  • 1A is a schematic flowchart of a method for matching clinical trial information between a clinical trial volunteer and a clinical trial supervising medical institution according to a preferred embodiment of the present invention.
  • the clinical trial volunteer terminal 100 receives and installs the clinical trial support app from the clinical trial information integration server 200 (S110).
  • the basic personal information and body information of the clinical trial volunteer are received and stored from the clinical trial volunteer terminal 100.
  • basic personal information includes gender, age (date of birth), contact information (email or mobile phone), and local information (volunteer address).
  • Physical information includes past and current medical history, weight, height, weight and height, BMI index, Blood type information, whether they have participated in the trial, whether they have participated in the trial within a specific time period (eg, within the last three months), or whether they smoked and drank, and how much and how much they smoked.
  • the clinical trial subject medical institution 300 that is, the search for the clinical trial volunteers announced from the pharmaceutical company, each medical group, medical institution or clinical trial conduct online search and collect the DB (not shown) Store in
  • the collected and stored clinical trial volunteers are classified, and the collected clinical trial volunteers are classified into disease names, medical departments, body parts, and regions (by clinical trial subject medical institution location). Recruitment announcement information can be generated.
  • cancer detailed lung cancer, non-small cell lung cancer, adenocarcinoma, gastric cancer, breast cancer, rectal cancer, lymphoma or multiple myeloma
  • diabetes arthritis, hepatitis, leukemia, high blood pressure, Alzheimer's disease, ulcer or asthma
  • family medicine internal medicine (in detail, infectious medicine, endocrine medicine, endocrine metabolism or rheumatology), surgery, neurology, anesthetic pain medicine, urology, radiation oncology, gynecology, radiology, ophthalmology, otolaryngology, rehabilitation medicine , Head / face (eyes, ears, nose, teeth, oral cavity, tongue, gums or jaw), neck / chest, abdomen, pelvis or arm /, by treatments such as mental health medicine, dentistry, dermatology, pediatric adolescents or clinical pharmacology.
  • body parts such as legs, it can be classified to generate recruitment information for clinical trial volunteers.
  • a basic digital questionnaire table for questioning the necessary items comprehensively corresponding to the clinical trial volunteer recruitment announcement information generated above is generated and stored.
  • the basic digital questionnaire is a pre-test questionnaire, and includes gender, age (date of birth), local information (volunteer address), weight, height, BMI index according to weight and height, blood type information, participation in clinical trials, and recent specific period ( For example, within the last three months), multiple-choice questions about whether or not you have participated in clinical trials, or whether smoking and drinking, and how much and how much you smoke.
  • the detailed clinical trial volunteer recruitment announcement and basic digital questionnaire provided by the clinical trial supervising medical institution 300 are classified by disease name, medical department, body part, and region. 100) can be provided in the form of clinical trial support app, but can also be provided in the form of web services.
  • the clinical trial volunteer questionnaire is generated according to the questionnaire content information inputted according to the basic digital questionnaire provided to the clinical trial volunteer terminal 100 and transmitted from the clinical trial volunteer terminal 100. do.
  • the basic digital questionnaire information and the clinical trial volunteer questionnaire information are compared to determine whether the clinical trial volunteer is eligible or ineligible for the clinical trial volunteer suitable for the clinical trial request.
  • the basic digital questionnaire information includes information on qualified or ineligible conditions for basic essential items that are comprehensively applicable to the clinical trial.
  • the determination step (S270) by analyzing the clinical trial volunteer questionnaire to filter (screen) whether or not overlapping clinical trial support within a specific period of time, it is possible to further determine the eligibility or ineligibility of the clinical trial subjects.
  • the clinical trial volunteer terminal 100 to promptly send by SNS, text or e-mail whether the clinical trial subjects qualified or ineligible.
  • the qualifying questionnaire providing step (S280) the qualified clinical trial volunteer questionnaire information is sent to SNS, text or e-mail to the clinical investigation subject medical institution 300 is provided quickly.
  • interview request information transmitting step S291 may be further performed to transmit the interview request information requested from the clinical trial administration medical institution 300 to the qualified volunteer terminal 100.
  • the call center for the subsequent services to the clinical trial volunteers and the clinical trial host medical institution may be on behalf of the processing of the work.
  • an additional digital questionnaire providing step (S292) may be further provided to generate an additional digital questionnaire requested by the clinical trial administration medical institution 300 and provide it to the eligible volunteer terminal 100.
  • the additional digital questionnaire providing step (S292) it is possible to provide an additional digital questionnaire including an additional or detailed subjective questionnaire according to the request of the clinical trial supervisor.
  • the basic digital questionnaire can quickly filter clinical trial volunteers to basic or standard questionnaire information that is comprehensively applied to clinical trials with low or low frequency of registration, thus preventing duplication of clinical trial volunteers within a specific period of time. Participation can be prevented, and the additional digital questionnaire transmits the interview request information to the qualified volunteer terminal 100 so that the candidates who are more optimized for the clinical trial can be selected.
  • it may further include a translation step (S293) for translating the domestic clinical trial information provided in a foreign language to the overseas clinical trial information site in Korean.
  • the clinical trial information should be announced to the Korea Food and Drug Administration or related overseas site according to the clinical trial disclosure principle.
  • the clinical trial volunteer terminal 100.
  • the clinical trial subject medical institution 300 may further include a registration and management step (S294) of directly receiving and registering the clinical trial subject medical institution information and clinical trial volunteer recruitment information without separate collection steps.
  • FIG. 1B is a schematic flowchart of an unregistered clinical trial processing step of the clinical trial information matching method of FIG. 1A.
  • a clinical trial volunteer for a specific clinical trial from the clinical trial volunteer terminal 100.
  • S295-2 To notify and to stop or extend the registration notification (S295-2).
  • the clinical trial information integration server 200 receives the clinical trial volunteer information from the clinical trial volunteer terminal 100 in advance for a rare disease or a desired clinical trial having a very low frequency of clinical trial volunteer notification.
  • the clinical trial volunteer recruitment announcement for the rare disease or desired clinical trial described above is registered from the clinical institution administering the clinical trial 300, the clinical trial information integrated server 200 is the clinical trial volunteer terminal 100
  • SNS Session Initiation Service
  • S295-1 Session 1
  • the clinical trial volunteer information received in advance includes information on the validity period of a specific clinical trial registration notification, and the clinical trial information integration server 200 determines whether to extend the validity period of the specific clinical trial registration notification at the end of the validity period. It may be transmitted to the volunteer terminal 100 and the corresponding registration notification may be stopped or extended (S295-2).
  • the restriction on access to the clinical trial information limited by the clinical trial supervising medical institution or region is eliminated, and a significant number of clinical trial volunteers' inquiries about eligibility for clinical trials are significantly increased. Reduce the efficiency of related tasks and implement correct medical ethics with transparent clinical trial volunteer information management.
  • bioequivalence test may further include the steps of collecting, classifying, generating, storing, providing, selecting, judging and informing the bioequivalence test.
  • the clinical institution managing the study encompasses the relevant server of the clinical research institution or the terminal of the clinical research institution.
  • the present invention collects the recruitment announcement of clinical trial volunteers announced by pharmaceutical companies, medical organizations, medical institutions or clinical trial institutes, and digitalizes the basic digital questionnaire information required for the clinical trial and the corresponding clinical trial volunteer questionnaire information.
  • the human resources and costs involved in recruiting the clinical trial volunteers and proceeding of the clinical trial Significant savings can be made to contribute to the health promotion of clinical trial volunteers, eliminating the restriction of clinical trial volunteers' access to clinical trial information limited by the clinical institution or region.
  • Clinical trial eligibility It can significantly reduce improve work efficiency, and transparency and it is industrially very useful as it can implement the preferred medical ethics in the right clinical trial volunteers information management.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Disclosed in the present invention is a method for matching clinical trial information between clinical trial volunteers and a medical institution conducting a clinical trial, comprising the steps of: a clinical trial information integration server collecting and categorizing clinical trial volunteer recruitment notices; generating a basic digital medical examination chart and providing same to a terminal of the clinical trial volunteers; comparing and determining eligible medical examination charts from among medical examination charts of the clinical trial volunteers and notifying eligibility through the terminal of the clinical trial volunteers. As a result, limitation to access to clinical trial information, which is limited by medical institutions conducting a clinical trial or by region, can be resolved, work efficiency can be increased by significantly reducing excessive inquiry calls made by clinical trial volunteers regarding clinical trial eligibility, and appropriate medical ethics can be observed by transparently managing clinical trial volunteer information.

Description

임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법Clinical trial information matching method between clinical trial volunteer and clinical research institute

본 발명은 임상시험정보 매칭 기술에 관한 것으로, 보다 상세하게는 온라인 상에서 임상시험 자원자와 임상시험 주관의료기관 또는 임상시험 주관의료기관 연구자 간의 임상시험정보를 매칭 하는 방법에 관한 것이다.The present invention relates to a clinical trial information matching technology, and more particularly, to a method for matching clinical trial information between a clinical trial volunteer and a clinical research institute or a research institute.

주지하는 바와 같이 특정 질병의 치료 또는 예방 의약을 개발하기 위해서는 상당한 기간과 노력이 소요되고, 치료제의 개발은 연구되는 후보 물질의 효능 및 부작용을 확인하기 위한 임상시험이 필수적으로 요구된다.As is well known, it takes considerable time and effort to develop a medicament for the treatment or prophylaxis of a particular disease, and the development of a therapeutic agent necessitates a clinical trial to confirm the efficacy and side effects of the candidate substance studied.

한편, 유의미한 임상시험 데이터를 얻기 위해서는 임상시험에 적합한 대상자를 모집하여야 하는 과정이 선행되는데, 불특정 다수를 향한 오프라인 임상시험 자원자 모집공고를 하거나 인터넷을 활용한 일방적인 임상시험 자원자 모집공고를 하는 실정이다.On the other hand, in order to obtain meaningful clinical trial data, the process of recruiting the candidates suitable for the clinical trial is preceded, and offline recruitment of volunteers for unspecified trials or unilateral recruitment of volunteers using the Internet is being made. .

하지만, 오프라인 임상시험 자원자 모집공고는 임상시험 주관의료기관의 지역적 한계에 따라 정보 접근성이 제약받아 유효기간 이내에 적합한 대상자를 모집하기 매우 어렵고, 전화 상담에 의해 기본적인 문진 과정을 거쳐야 하는 번거로움과 업무 자원의 낭비가 상존한다.However, it is very difficult to recruit suitable candidates within the period of validity because of limited access to information due to the regional limitations of the clinical institution in charge of the study. Waste is present

또한, 인터넷을 통한 임상시험 자원자 모집공고는 지역적 한계를 극복할 수 있으나, 임상시험 주관의료기관 간 임상시험 자원자 정보의 비공개로 인해 중복 자원자의 필터링이 불가능한 문제점이 있다.In addition, the recruitment announcement of clinical trial volunteers through the Internet can overcome local limitations, but there is a problem that filtering of duplicate volunteers is impossible due to the confidentiality of clinical trial volunteer information between the clinical trial supervisors.

본 발명은 상기한 종래 기술의 문제점을 해소하기 위해 안출된 것으로, 임상시험 주관의료기관으로부터 제공되는 임상시험 자원자 모집공고를 온라인 상에서 수집하고, 임상시험에 요구되는 기본 디지털 문진표와 임상시험 자원자 문진표 정보를 디지털화하여 매칭하고 임상시험 대상자 적격 또는 부적격을 선별하여 필터링할 수 있는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법을 제공하는 것을 그 과제로 한다.The present invention has been made to solve the above-mentioned problems of the prior art, collects the clinical trial volunteer recruitment provided from the clinical institution in charge of the investigation online, and the basic digital questionnaire information and clinical trial volunteer questionnaire information required for the clinical trial The task is to provide a method for matching clinical trial information between clinical trial volunteers and clinical research institutes that can be digitally matched and screened and filtered eligible or ineligible subjects.

본 발명이 해결하고자 하는 기술적 과제는 이상에서 언급한 기술적 과제로 제한될 필요는 없으며, 언급되지 않은 또 다른 기술적 과제들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.The technical problem to be solved by the present invention does not need to be limited to the technical problem mentioned above, and other technical problems that are not mentioned are clearly to those skilled in the art from the following description. It can be understood.

전술한 과제를 달성하기 위하여, 본 발명의 실시예는 임상시험 자원자 단말기로 임상시험정보 통합서버로부터 임상시험지원 앱을 전송받아 설치하는 단계 및 상기 임상시험정보 통합서버가, 상기 임상시험 자원자 단말기로부터 임상시험 자원자의 기본 신상 정보 및 신체 정보를 수신하여 저장하는 단계와, 임상시험 주관의료기관으로부터 공고되는 임상시험 자원자 모집공고를 온라인 상에서 검색하고 수집하는 단계와, 상기 수집된 임상시험 자원자 모집공고를 분류하는 단계와, 상기 임상시험 자원자 모집공고정보에 해당하는 기본 디지털 문진표를 생성하여 저장하는 단계와, 상기 임상시험 자원자 모집공고 및 상기 기본 디지털 문진표를 상기 임상시험 자원자 단말기로 제공하는 단계와, 상기 임상시험 자원자 단말기로 제공된 상기 기본 디지털 문진표에 따라 입력되어 상기 임상시험 자원자 단말기로부터 전송된 정보에 따라 임상시험 자원자 문진표를 생성하는 단계와, 상기 기본 디지털 문진표 정보와 상기 임상시험 자원자 문진표 정보를 비교하여 임상시험 대상자 적격 또는 부적격을 판단하는 단계와, 상기 임상시험 자원자 단말기로 임상시험 대상자 적격 또는 부적격 여부를 통보하는 단계와, 적격 임상시험 자원자 문진표 정보를 상기 임상시험 주관의료기관으로 제공하는 단계로 구성되는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법을 제공한다.In order to achieve the above object, an embodiment of the present invention is to receive and install the clinical trial support app from the clinical trial information integrated server to the clinical trial volunteer terminal and the clinical trial information integrated server, from the clinical trial volunteer terminal Receiving and storing basic personal and physical information of a clinical trial volunteer; searching and collecting the clinical trial volunteer recruitment notice announced by the clinical research institute; and classifying the collected clinical trial volunteer recruitment notice. And generating and storing the basic digital questionnaire corresponding to the clinical trial volunteer recruitment information, and providing the clinical trial volunteer recruitment announcement and the basic digital questionnaire to the clinical trial volunteer terminal. The basic digital provided to the test volunteer terminal Generating a clinical trial volunteer questionnaire according to the information inputted from the questionnaire and transmitted from the clinical trial volunteer terminal, and comparing the basic digital questionnaire information and the clinical trial volunteer questionnaire information to determine eligibility or ineligibility of the clinical trial subject Between the clinical trial volunteer and the clinical trial management institution, comprising: informing the clinical volunteer volunteer terminal whether the clinical trial candidate is eligible or ineligible; and providing the clinical trial volunteer questionnaire information to the primary clinical research institute. Provide clinical information matching method.

바람직하게는, 상기 수집된 임상시험 자원자 모집공고를 질병명과 진료과와 신체부위별과 지역별로 분류하여 임상시험 자원자 모집공고정보를 생성할 수 있다.Preferably, the collected clinical trial volunteer recruitment notification may be classified by disease name, medical department, body part, and region to generate the clinical trial volunteer recruitment information.

바람직하게는, 상기 임상시험 주관의료기관으로부터 요청되는 추가 디지털 문진표를 생성하여 상기 적격 자원자 단말기로 제공하는 단계를 더 포함할 수 있다.Preferably, the method may further include generating an additional digital questionnaire requested by the clinical trial management institution and providing it to the qualified volunteer terminal.

바람직하게는, 상기 추가 디지털 문진표는 주관식 설문을 포함할 수 있다.Advantageously, said additional digital questionnaire may comprise a short answer questionnaire.

바람직하게는, 상기 적격 자원자 단말기로 상기 임상시험 주관의료기관으로부터 요청되는 면접요청정보를 전송하는 단계를 더 포함할 수 있다.Preferably, the method may further include transmitting the interview request information requested from the clinical trial management institution to the qualified volunteer terminal.

바람직하게는, 해외 임상시험정보 사이트에 외국어로 제공되는 국내 임상시험정보를 국어로 번역하여 제공하는 단계를 더 포함할 수 있다.Preferably, the method may further include translating and providing a domestic clinical trial information provided in a foreign language to a foreign clinical trial information site in a Korean language.

바람직하게는, 상기 임상시험 자원자 문진표를 분석하여 특정기간 이내의 임상시험 중복 지원을 필터링하여 임상시험 대상자 적격 또는 부적격을 추가적으로 판단할 수 있다.Preferably, the clinical trial volunteer questionnaire may be analyzed to further filter the clinical trial overlap support within a specific period of time to further determine the eligibility or ineligibility of the clinical trial subject.

바람직하게는, 상기 임상시험 주관의료기관으로부터 임상시험 주관의료기관정보 및 임상시험 자원자 모집공고정보를 전송받아 등록 및 관리하는 단계를 더 포함할 수 있다.Preferably, the method may further include the step of receiving registration and management of clinical trial subject medical institution information and clinical trial volunteer recruitment information from the clinical trial subject medical institution.

바람직하게는, 상기 임상시험 주관의료기관에 의해 공고되지 않은 특정 임상시험에 대해서, 상기 임상시험 자원자 단말기로부터 상기 특정 임상시험에 대한 임상시험 자원자 정보를 선행적으로 수신하여 저장하고, 추후 상기 임상시험 주관의료기관으로부터 상기 특정 임상시험에 대한 임상시험 자원자 모집공고가 등록되면, 상기 임상시험 자원자 단말기로 상기 임상시험 자원자 모집공고 등록을 통보하고, 상기 사전에 전송받은 임상시험 자원자 정보에는 상기 특정 임상시험 등록 알림의 유효기간 정보를 포함하며, 상기 유효기간 종료시점에 상기 특정 임상시험 등록 알림 유효기간 연장 여부를 상기 임상시험 자원자 단말기로 통보하고 이에 대해 해당 등록 알림을 중단하거나 연장하도록 하는 단계를 더 포함할 수도 있다.Preferably, for a specific clinical trial not announced by the clinical trial supervisory medical institution, the trial volunteer information for the specific clinical trial is first received and stored from the clinical trial volunteer terminal, and subsequently, the clinical trial administration When the clinical trial volunteer recruitment notice for the specific clinical trial is registered from a medical institution, the clinical trial volunteer recruitment notification is notified to the clinical trial volunteer terminal, and the clinical trial volunteer information received in advance transmits the specific clinical trial registration notification. It may include a period of validity information, and further comprising the step of notifying the clinical volunteer volunteer terminal whether the extension of the validity of the specific clinical trial registration notification at the end of the validity period and to stop or extend the registration notification for this; have.

본 발명에 의하면, 제약사, 각 의료단체, 의료기관 또는 임상시험 실시기관에서 공고하여 시행하는 임상시험 자원자 모집공고를 수집하여 임상시험에 요구되는 기본 디지털 문진표 정보와 해당 임상시험 자원자 문진표 정보를 디지털화하여 매칭한 후, 임상시험에 가장 적합한 임상시험 자원자를 적격자와 부적격자로 용이하게 선별할 수 있도록 하고, 적격자 중에서는 특정기간 내 중복 임상시험 자원자를 필터링하여 임상시험 자원자 모집 및 임상시험 진행과정에서 수반되는 인력 및 비용을 현저히 절감시킬 수 있도록 함으로써, 임상시험 자원자의 건강증진에 기여할 수 있는 효과가 있다.According to the present invention, by collecting the clinical trial volunteer recruitment announcement announced by the pharmaceutical company, each medical organization, medical institution or clinical trial conducting institution to digitally match the basic digital questionnaire information required for the clinical trial and the corresponding clinical trial volunteer questionnaire information Afterwards, the most appropriate clinical trial volunteers for the clinical trial can be easily selected as qualified and ineligible candidates, and among the qualified persons, the overlapping clinical trial volunteers are filtered within a specific period of time, and the personnel involved in the recruitment of clinical trial volunteers and the clinical trial process. And by reducing the cost significantly, there is an effect that can contribute to the health promotion of the clinical trial volunteers.

또한, 임상시험 주관의료기관별로 또는 지역별로 제한되는 임상시험정보로의 임상시험 자원자의 접근 제약을 해소할 수 있으며, 임상시험 자원자의 과도한 임상시험 적격 여부 문의전화를 현저히 줄여 업무 효율성을 향상시킬 수 있고, 투명하고 올바른 임상시험 자원자 정보 관리로 바람직한 의료 윤리를 구현할 수 있는 효과가 있다.In addition, it is possible to remove the restriction of clinical trial volunteers 'access to clinical trial information limited by the clinical institution or region, and to improve work efficiency by significantly reducing the number of clinical trial volunteers' inquiries about eligibility for excessive clinical trials. In addition, transparent and sound management of clinical trial volunteer information has the effect of achieving good medical ethics.

여기서, 이와 같이 기재된 본 발명의 효과는 발명자가 인지하는지 여부와 무관하게 기재된 내용의 구성에 의해 당연히 발휘되게 되는 것이므로 상술한 효과는 기재된 내용에 따른 몇 가지 효과일 뿐 발명자가 파악한 또는 실재하는 모든 효과를 기재한 것이라 인정되어서는 안 된다. Here, since the effects of the present invention described above are naturally manifested by the configuration of the described contents irrespective of whether or not the inventor recognizes them, the above-described effects are only some effects according to the described contents, and all the effects grasped or actual by the inventors. It should not be accepted that it is listed.

도 1a는 본 발명의 바람직한 실시예에 의한 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법의 개략적인 흐름도이다.1A is a schematic flowchart of a method for matching clinical trial information between a clinical trial volunteer and a clinical trial supervising medical institution according to a preferred embodiment of the present invention.

도 1b는 도 1a의 임상시험정보 매칭 방법의 미등록 임상시험 처리 단계의 개략적인 흐름도이다.FIG. 1B is a schematic flowchart of an unregistered clinical trial processing step of the clinical trial information matching method of FIG. 1A.

이하, 첨부된 도면을 참조로 전술한 특징으로 갖는 본 발명의 실시예를 더욱 상세히 설명하고자 한다.Hereinafter, with reference to the accompanying drawings will be described in detail an embodiment of the present invention having the features described above.

도 1a은 본 발명의 바람직한 실시예에 의한 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법의 개략적인 흐름도이다.1A is a schematic flowchart of a method for matching clinical trial information between a clinical trial volunteer and a clinical trial supervising medical institution according to a preferred embodiment of the present invention.

도 1a을 참조하면, 본 발명의 바람직한 실시예에 따른 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법은, 임상시험지원 앱 전송단계(S110), 자원자정보 저장단계(S210), 수집단계(S220), 분류단계(S230), 생성단계(S240), 기본 디지털 문진표 제공단계(S250), 임상시험 자원자 문진표 생성단계(S260), 판단단계(S270) 및 적격 문진표 제공단계(280)를 포함한다.Referring to Figure 1a, the clinical trial information matching method between the clinical trial volunteer and the clinical trial host medical institution according to the preferred embodiment of the present invention, clinical trial support app transmission step (S110), volunteer information storage step (S210), the collection step (S220), classification step (S230), generation step (S240), the basic digital questionnaire providing step (S250), clinical trial volunteer questionnaire generation step (S260), determination step (S270) and eligible questionnaire providing step 280 do.

우선, 임상시험지원 앱 전송단계(S110)에서는, 임상시험 자원자 단말기(100)가 임상시험정보 통합서버(200)로부터 임상시험지원 앱을 전송받아 설치한다(S110).First, in the clinical trial support app transmission step (S110), the clinical trial volunteer terminal 100 receives and installs the clinical trial support app from the clinical trial information integration server 200 (S110).

이후, 자원자정보 저장단계(S210)에서는, 임상시험 자원자 단말기(100)로부터 임상시험 자원자의 기본 신상 정보 및 신체 정보를 수신하여 저장한다. 예컨대, 기본 신상 정보로서는 성별, 연령(생년월일), 연락처(이메일 또는 휴대폰) 및 지역 정보(자원자 주소)를 포함하고, 신체 정보로서는 과거와 현재 병력, 체중, 키, 체중과 키에 따른 BMI 지수, 혈액형 정보, 임상시험 참여 경험 여부, 최근 특정 기간 내(예컨대, 최근 3개월 내) 임상시험 참여 경험 여부, 또는 흡연 및 음주 여부와 흡연량 및 음주량을 포함한다.Thereafter, in the volunteer information storage step (S210), the basic personal information and body information of the clinical trial volunteer are received and stored from the clinical trial volunteer terminal 100. For example, basic personal information includes gender, age (date of birth), contact information (email or mobile phone), and local information (volunteer address). Physical information includes past and current medical history, weight, height, weight and height, BMI index, Blood type information, whether they have participated in the trial, whether they have participated in the trial within a specific time period (eg, within the last three months), or whether they smoked and drank, and how much and how much they smoked.

이후, 수집단계(S220)에서는, 임상시험 주관의료기관(300), 즉 제약사, 각 의료단체, 의료기관 또는 임상시험 실시기관으로부터 공고되는 임상시험 자원자 모집공고를 온라인 상에서 검색하고 수집하여 DB(미도시)에 저장한다.Then, in the collection step (S220), the clinical trial subject medical institution 300, that is, the search for the clinical trial volunteers announced from the pharmaceutical company, each medical group, medical institution or clinical trial conduct online search and collect the DB (not shown) Store in

이후, 분류단계(S230)에서는, 수집 저장된 임상시험 자원자 모집공고를 분류하는데, 수집된 임상시험 자원자 모집공고를 질병명과 진료과와 신체부위별과 지역별(임상시험 주관의료기관 위치별)로 분류하여 임상시험 자원자 모집공고정보를 생성할 수 있다.Subsequently, in the classification step (S230), the collected and stored clinical trial volunteers are classified, and the collected clinical trial volunteers are classified into disease names, medical departments, body parts, and regions (by clinical trial subject medical institution location). Recruitment announcement information can be generated.

예컨대, 분류단계(S230)에서는, 암(세부적으로 폐암, 비소세포폐암, 선암, 위암, 유방암, 직장암, 림프종 또는 다발성 골수종), 당뇨, 관절염, 간염, 백혈병, 고혈압, 알츠하이머, 궤양 또는 천식과 같은 질병명 별로, 가정의학과, 내과(세부적으로, 감염내과, 내분비내과, 내분비대사내과 또는 류마티스내과), 외과, 신경과, 마취통증의학, 비뇨기과, 방사선종양학, 산부인과, 영상의학과, 안과, 이비인후과, 재활의학과, 정신건강의학, 치과, 피부과, 소아청소년 또는 임상약리학과 같은 진료과 별로, 머리/얼굴(눈, 귀, 코, 치아, 구강, 혀, 잇몸 또는 턱), 목/가슴, 복부, 골반 또는 팔/다리와 같은 신체부위 별로, 분류하여 임상시험 자원자 모집공고정보를 생성할 수 있다.For example, in the classification step S230, cancer (detailed lung cancer, non-small cell lung cancer, adenocarcinoma, gastric cancer, breast cancer, rectal cancer, lymphoma or multiple myeloma), diabetes, arthritis, hepatitis, leukemia, high blood pressure, Alzheimer's disease, ulcer or asthma By disease name, family medicine, internal medicine (in detail, infectious medicine, endocrine medicine, endocrine metabolism or rheumatology), surgery, neurology, anesthetic pain medicine, urology, radiation oncology, gynecology, radiology, ophthalmology, otolaryngology, rehabilitation medicine , Head / face (eyes, ears, nose, teeth, oral cavity, tongue, gums or jaw), neck / chest, abdomen, pelvis or arm /, by treatments such as mental health medicine, dentistry, dermatology, pediatric adolescents or clinical pharmacology. By body parts, such as legs, it can be classified to generate recruitment information for clinical trial volunteers.

이후, 생성단계(S240)에서는, 앞서 생성된 임상시험 자원자 모집공고정보에 포괄적으로 해당하는 필수 항목을 문진하는 기본 디지털 문진표를 생성하여 저장한다.Subsequently, in the generation step (S240), a basic digital questionnaire table for questioning the necessary items comprehensively corresponding to the clinical trial volunteer recruitment announcement information generated above is generated and stored.

여기서, 기본 디지털 문진표는 사전 문진표로서, 성별, 연령(생년월일), 지역 정보(자원자 주소), 체중, 키, 체중과 키에 따른 BMI 지수, 혈액형 정보, 임상시험 참여 경험 여부, 최근 특정 기간 내(예컨대, 최근 3개월 내) 임상시험 참여 경험 여부, 또는 흡연 및 음주 여부와 흡연량 및 음주량에 대한 객관식 설문 내용을 포함한다.Here, the basic digital questionnaire is a pre-test questionnaire, and includes gender, age (date of birth), local information (volunteer address), weight, height, BMI index according to weight and height, blood type information, participation in clinical trials, and recent specific period ( For example, within the last three months), multiple-choice questions about whether or not you have participated in clinical trials, or whether smoking and drinking, and how much and how much you smoke.

이후, 기본 디지털 문진표 제공단계(S250)에서는, 임상시험 주관의료기관(300)으로부터 제공되는 상세한 임상시험 자원자 모집공고 및 기본 디지털 문진표를 질병명과 진료과와 신체부위별과 지역별로 구분하여서 임상시험 자원자 단말기(100)로 임상시험지원 앱 형태로 제공할 수 있으나, 웹서비스 형태로도 제공할 수 있다.Subsequently, in the basic digital questionnaire providing step (S250), the detailed clinical trial volunteer recruitment announcement and basic digital questionnaire provided by the clinical trial supervising medical institution 300 are classified by disease name, medical department, body part, and region. 100) can be provided in the form of clinical trial support app, but can also be provided in the form of web services.

이후, 임상시험 자원자 문진표 생성단계(S260)에서는, 임상시험 자원자 단말기(100)로 제공된 기본 디지털 문진표에 따라 입력되어 임상시험 자원자 단말기(100)로부터 전송된 문진 내용 정보에 따라 임상시험 자원자 문진표를 생성한다.Then, in the clinical trial volunteer questionnaire generation step (S260), the clinical trial volunteer questionnaire is generated according to the questionnaire content information inputted according to the basic digital questionnaire provided to the clinical trial volunteer terminal 100 and transmitted from the clinical trial volunteer terminal 100. do.

이후, 판단단계(S270)에서는, 기본 디지털 문진표 정보와 임상시험 자원자 문진표 정보를 비교하여 임상시험요구에 적합한 임상시험 자원자의 임상시험 대상자 적격 또는 부적격을 판단하여 구분한다. 여기서, 기본 디지털 문진표 정보는 임상시험에 포괄적으로 해당하는 기본적인 필수 항목에 대한 적격 또는 부적격 조건 정보를 포함한다.Subsequently, in the determination step (S270), the basic digital questionnaire information and the clinical trial volunteer questionnaire information are compared to determine whether the clinical trial volunteer is eligible or ineligible for the clinical trial volunteer suitable for the clinical trial request. Here, the basic digital questionnaire information includes information on qualified or ineligible conditions for basic essential items that are comprehensively applicable to the clinical trial.

한편, 판단단계(S270)에서는, 임상시험 자원자 문진표를 분석하여 임상시험 자원자의 특정기간 이내의 임상시험 중복 지원 여부를 필터링(스크린)하여서, 임상시험 대상자 적격 또는 부적격을 추가적으로 판단할 수 있다.On the other hand, in the determination step (S270), by analyzing the clinical trial volunteer questionnaire to filter (screen) whether or not overlapping clinical trial support within a specific period of time, it is possible to further determine the eligibility or ineligibility of the clinical trial subjects.

이후, 통보단계(S270)에서는, 임상시험 자원자 단말기(100)로 임상시험 대상자 적격 또는 부적격 여부를 SNS, 문자 또는 이메일로 전송하여 신속하게 통보한다.Thereafter, in the notification step (S270), the clinical trial volunteer terminal 100 to promptly send by SNS, text or e-mail whether the clinical trial subjects qualified or ineligible.

이후, 적격 문진표 제공단계(S280)에서는, 적격 임상시험 자원자 문진표 정보를 임상시험 주관의료기관(300)으로 SNS, 문자 또는 이메일로 전송하여 신속하게 제공한다.Then, in the qualifying questionnaire providing step (S280), the qualified clinical trial volunteer questionnaire information is sent to SNS, text or e-mail to the clinical investigation subject medical institution 300 is provided quickly.

한편, 임상시험 주관의료기관(300)으로부터 요청되는 면접요청정보를 적격 자원자 단말기(100)로 전송하는 면접요청정보 전송단계(S291)를 더 포함할 수 있다.Meanwhile, the interview request information transmitting step S291 may be further performed to transmit the interview request information requested from the clinical trial administration medical institution 300 to the qualified volunteer terminal 100.

여기서, 면접요청정보 전송단계(S291)에서는, 임상시험 자원자 및 임상시험 주관의료기관에 대한 후속적인 서비스를 위한 콜센터의 업무처리를 대행할 수도 있다.Here, in the interview request information transmission step (S291), the call center for the subsequent services to the clinical trial volunteers and the clinical trial host medical institution may be on behalf of the processing of the work.

또한, 임상시험 주관의료기관(300)으로부터 요청되는 추가 디지털 문진표를 생성하여서 적격 자원자 단말기(100)로 제공하는, 추가 디지털 문진표 제공단계(S292)를 더 포함할 수 있다.In addition, an additional digital questionnaire providing step (S292) may be further provided to generate an additional digital questionnaire requested by the clinical trial administration medical institution 300 and provide it to the eligible volunteer terminal 100.

여기서, 추가 디지털 문진표 제공단계(S292)에서는, 임상시험 주관의료기관의 요구에 따른 추가적인 또는 세부적인 주관식 설문을 포함하는 추가 디지털 문진표를 제공할 수 있다.Here, in the additional digital questionnaire providing step (S292), it is possible to provide an additional digital questionnaire including an additional or detailed subjective questionnaire according to the request of the clinical trial supervisor.

즉, 기본 디지털 문진표는 임상시험 자원자를 통상적이거나 등록 빈도가 낮지 않은 임상시험에 포괄적으로 적용되는 기본적인 또는 표준적인 문진 정보로 신속하게 필터링하여 특정기간 내 임상시험 자원자의 중복 참여를 방지하여 무분별한 임상시험 참여를 지양시킬 수 있고, 추가 디지털 문진표는 적격 자원자 단말기(100)로 면접요청정보를 전송한 후 적격자 중 해당 임상시험에 보다 최적화된 대상자를 선별할 수 있도록 한다.In other words, the basic digital questionnaire can quickly filter clinical trial volunteers to basic or standard questionnaire information that is comprehensively applied to clinical trials with low or low frequency of registration, thus preventing duplication of clinical trial volunteers within a specific period of time. Participation can be prevented, and the additional digital questionnaire transmits the interview request information to the qualified volunteer terminal 100 so that the candidates who are more optimized for the clinical trial can be selected.

또한, 해외 임상시험정보 사이트에 외국어로 제공되는 국내 임상시험정보를 국어로 번역하여 제공하는 번역단계(S293)를 더 포함할 수 있다.In addition, it may further include a translation step (S293) for translating the domestic clinical trial information provided in a foreign language to the overseas clinical trial information site in Korean.

예컨대, 번역단계(S293)에서는, 번역에 특화된 인공지능으로서, 임상시험 공개원칙에 따라 국내 식약처 또는 관련 해외 사이트에 임상시험정보를 공고하여야 하는데, 관련 해외 사이트에 공고되는 임상시험 자원자 모집공고로의 접근성 및 이해도를 높이기 위해서 국어로 번역하여 임상시험 자원자 단말기(100)로 제공할 수도 있다.For example, in the translation step S293, as an artificial intelligence specialized for translation, the clinical trial information should be announced to the Korea Food and Drug Administration or related overseas site according to the clinical trial disclosure principle. In order to improve the accessibility and understanding of the translation into Korean may be provided to the clinical trial volunteer terminal (100).

또한, 임상시험 주관의료기관(300)으로부터 임상시험 주관의료기관정보 및 임상시험 자원자 모집공고정보를 개별적인 수집 단계 없이 직접 전송받아 등록 및 관리하는 등록 및 관리 단계(S294)를 더 포함할 수 있다.In addition, the clinical trial subject medical institution 300 may further include a registration and management step (S294) of directly receiving and registering the clinical trial subject medical institution information and clinical trial volunteer recruitment information without separate collection steps.

도 1b는 도 1a의 임상시험정보 매칭 방법의 미등록 임상시험 처리 단계의 개략적인 흐름도이다.FIG. 1B is a schematic flowchart of an unregistered clinical trial processing step of the clinical trial information matching method of FIG. 1A.

도 1b를 참조하면, 미등록 임상시험 처리 단계(S295)에서는, 임상시험 주관의료기관(300)에 의해 공고되지 않은 특정 임상시험에 대해서, 임상시험 자원자 단말기(100)로부터 특정 임상시험에 대한 임상시험 자원자 정보를 선행적으로 수신하여 저장하고, 추후 임상시험 주관의료기관(300)으로부터 특정 임상시험에 대한 임상시험 자원자 모집공고가 등록되면, 임상시험 자원자 단말기(100)로 임상시험 자원자 모집공고 등록을 통보하고(S295-1), 사전에 전송받은 임상시험 자원자 정보에는 특정 임상시험 등록 알림의 유효기간 정보를 포함하며, 유효기간 종료시점에 특정 임상시험 등록 알림 유효기간 연장 여부를 임상시험 자원자 단말기(100)로 통보하고 이에 대해 해당 등록 알림을 중단하거나 연장하도록 한다(S295-2).Referring to FIG. 1B, in a non-registered clinical trial processing step (S295), for a specific clinical trial not announced by the clinical trial supervisory medical institution 300, a clinical trial volunteer for a specific clinical trial from the clinical trial volunteer terminal 100. Receive prior information and store the information, and if the clinical trial volunteer recruitment announcement for a specific clinical trial is registered in the future clinical trial supervision medical institution 300, and informs the clinical trial volunteer recruitment registration to the clinical trial volunteer terminal 100 (S295-1), the clinical trial volunteer information received in advance includes the expiration date information of the specific clinical trial registration notification, and the clinical trial volunteer terminal 100 whether to extend the validity period of the specific clinical trial registration notification at the end of the validity period (S295-1). To notify and to stop or extend the registration notification (S295-2).

예컨대, 일반 질병과 달리, 임상시험 자원자 공고 빈도가 매우 낮은 희귀 질병 또는 희망 임상시험에 대해서, 임상시험정보 통합서버(200)가 임상시험 자원자 단말기(100)로부터 임상시험 자원자 정보를 사전에 전송받아 DB에 저장한 후, 추후 임상시험 주관의료기관(300)으로부터 전술한 희귀 질병 또는 희망 임상시험에 대한 임상시험 자원자 모집공고가 등록되면, 임상시험정보 통합서버(200)가 임상시험 자원자 단말기(100)로 임상시험 자원자 모집공고 등록 알림 및 임상시험 지원자 모집공고를 SNS, 문자 또는 이메일로 통보한다(S295-1).For example, unlike a general disease, the clinical trial information integration server 200 receives the clinical trial volunteer information from the clinical trial volunteer terminal 100 in advance for a rare disease or a desired clinical trial having a very low frequency of clinical trial volunteer notification. After storing in the DB, the clinical trial volunteer recruitment announcement for the rare disease or desired clinical trial described above is registered from the clinical institution administering the clinical trial 300, the clinical trial information integrated server 200 is the clinical trial volunteer terminal 100 As a result, SNS, a text message, or an e-mail notification of the registration notification of clinical trial volunteer recruitment and the notification of clinical trial volunteer recruitment (S295-1).

또한, 사전에 전송받은 임상시험 자원자 정보에는 특정 임상시험 등록 알림의 유효기간 정보를 포함하고, 임상시험정보 통합서버(200)는 유효기간 종료시점에 특정한 임상시험 등록 알림 유효기간 연장 여부를 임상시험 자원자 단말기(100)로 전송하고 이에 대해 해당 등록 알림을 중단하거나 연장할 수도 있다(S295-2).In addition, the clinical trial volunteer information received in advance includes information on the validity period of a specific clinical trial registration notification, and the clinical trial information integration server 200 determines whether to extend the validity period of the specific clinical trial registration notification at the end of the validity period. It may be transmitted to the volunteer terminal 100 and the corresponding registration notification may be stopped or extended (S295-2).

따라서, 전술한 바와 같은 임상시험정보 매칭 방법의 구성에 의해서, 임상시험 주관의료기관별로 또는 지역별로 제한되는 임상시험정보로의 접근 제약을 해소하며, 임상시험 자원자의 과도한 임상시험 적격 여부 문의전화를 현저히 줄여 관련 업무의 효율성을 증대하고, 투명한 임상시험 자원자 정보 관리로 올바른 의료 윤리를 구현한다.Therefore, by configuring the clinical trial information matching method as described above, the restriction on access to the clinical trial information limited by the clinical trial supervising medical institution or region is eliminated, and a significant number of clinical trial volunteers' inquiries about eligibility for clinical trials are significantly increased. Reduce the efficiency of related tasks and implement correct medical ethics with transparent clinical trial volunteer information management.

한편, 임상시험과 (생물학적) 생동성시험은 엄격히 구분되는 개념으로서, 앞서 임상시험에 관한 매칭 기술에 관해서만 상세히 기재하였으나, 본 발명에 의한 매칭 방법은 생동성시험에도 동일하게 적용될 수 있으며, 임상시험 또는 생동성시험을 구분하여 수집, 분류, 생성, 저장, 제공, 선택, 판단 및 통보하는 단계를 추가적으로 포함할 수 있다.On the other hand, clinical trials and (biological) bioequivalence tests are strictly distinguished concepts, but only the matching techniques related to the clinical trials have been described in detail above, but the matching method according to the present invention may be equally applicable to bioequivalence studies, and The bioequivalence test may further include the steps of collecting, classifying, generating, storing, providing, selecting, judging and informing the bioequivalence test.

또한, 임상시험 주관의료기관은 임상시험 주관의료기관의 관련 서버 또는 임상시험 주관의료기관 연구자의 단말기를 포괄하는 것으로 이해될 수도 있다.In addition, it may be understood that the clinical institution managing the study encompasses the relevant server of the clinical research institution or the terminal of the clinical research institution.

본 명세서에 기재된 실시 예와 도면에 도시된 구성은 본 발명의 가장 바람직한 일 실시 예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원 시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형 예들이 있을 수 있음을 이해하여야 한다.Configurations shown in the embodiments and drawings described herein are only one of the most preferred embodiments of the present invention, and do not represent all of the technical spirit of the present invention, various equivalents that may be substituted for them at the time of the present application It should be understood that there may be water and variations.

본 발명은 제약사, 각 의료단체, 의료기관 또는 임상시험 실시기관에서 공고하여 시행하는 임상시험 자원자 모집공고를 수집하여 임상시험에 요구되는 기본 디지털 문진표 정보와 해당 임상시험 자원자 문진표 정보를 디지털화한 후 매칭하여 임상시험에 가장 적합한 임상시험 자원자를 적격자와 부적격자로 용이하게 선별할 수 있도록 하고, 적격자 중에서는 특정기간 내 중복 임상시험 자원자를 필터링하여 임상시험 자원자 모집 및 임상시험 진행과정에서 수반되는 인력 및 비용을 현저히 절감시킬 수 있도록 함으로써, 임상시험 자원자의 건강증진에 기여할 수 있으며, 임상시험 주관의료기관별로 또는 지역별로 제한되는 임상시험정보로의 임상시험 자원자의 접근 제약을 해소할 수 있고, 임상시험 자원자의 과도한 임상시험 적격 여부 문의전화를 현저히 줄여 업무 효율성을 향상시킬 수 있으며, 투명하고 올바른 임상시험 자원자 정보 관리로 바람직한 의료 윤리를 구현할 수 있어 산업적으로 매우 유용하다.The present invention collects the recruitment announcement of clinical trial volunteers announced by pharmaceutical companies, medical organizations, medical institutions or clinical trial institutes, and digitalizes the basic digital questionnaire information required for the clinical trial and the corresponding clinical trial volunteer questionnaire information. To make it easier to select the most appropriate clinical trial volunteers for the clinical trial as eligible and ineligible, and to filter the duplicated clinical trial volunteers within a specific period of time, the human resources and costs involved in recruiting the clinical trial volunteers and proceeding of the clinical trial Significant savings can be made to contribute to the health promotion of clinical trial volunteers, eliminating the restriction of clinical trial volunteers' access to clinical trial information limited by the clinical institution or region. Clinical trial eligibility It can significantly reduce improve work efficiency, and transparency and it is industrially very useful as it can implement the preferred medical ethics in the right clinical trial volunteers information management.

Claims (9)

임상시험 자원자 단말기가 임상시험정보 통합서버로부터 임상시험지원 앱을 전송받아 설치하는 단계; 및A clinical trial volunteer terminal receiving and installing a clinical trial support app from an integrated clinical trial information server; And 상기 임상시험정보 통합서버가, 상기 임상시험 자원자 단말기로부터 임상시험 자원자의 기본 신상 정보 및 신체 정보를 수신하여 저장하는 단계와, 임상시험 주관의료기관으로부터 공고되는 임상시험 자원자 모집공고를 온라인 상에서 검색하고 수집하는 단계와, 상기 수집된 임상시험 자원자 모집공고를 분류하는 단계와, 상기 임상시험 자원자 모집공고정보에 해당하는 기본 디지털 문진표를 생성하여 저장하는 단계와, 상기 임상시험 자원자 모집공고 및 상기 기본 디지털 문진표를 상기 임상시험 자원자 단말기로 제공하는 단계와, 상기 임상시험 자원자 단말기로 제공된 상기 기본 디지털 문진표에 따라 입력되어 상기 임상시험 자원자 단말기로부터 전송된 정보에 따라 임상시험 자원자 문진표를 생성하는 단계와, 상기 기본 디지털 문진표 정보와 상기 임상시험 자원자 문진표 정보를 비교하여 임상시험 대상자 적격 또는 부적격을 판단하는 단계와, 상기 임상시험 자원자 단말기로 임상시험 대상자 적격 또는 부적격 여부를 통보하는 단계와, 적격 임상시험 자원자 문진표 정보를 상기 임상시험 주관의료기관으로 제공하는 단계;The clinical trial information integration server, receiving and storing basic personal information and physical information of the clinical trial volunteer from the clinical trial volunteer terminal, and searching and collecting the clinical trial volunteer recruitment notice announced from the clinical research institute. And classifying the collected clinical trial volunteer recruitment announcement, generating and storing a basic digital questionnaire corresponding to the clinical trial volunteer announcement information, and storing the clinical trial volunteer recruitment announcement and the basic digital questionnaire. Providing to the clinical trial volunteer terminal, generating a clinical trial volunteer questionnaire according to the information transmitted from the clinical trial volunteer terminal inputted according to the basic digital questionnaire provided to the clinical trial volunteer terminal, and Digital Questionnaire Information Comparing the clinical trial volunteer questionnaire information to determine whether the clinical trial candidate is eligible or ineligible; notifying the clinical trial volunteer terminal whether the clinical trial candidate is eligible or ineligible; and the qualified clinical trial volunteer questionnaire information. Providing to the host medical institution; 로 구성되는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.Clinical trial information matching method between the clinical trial volunteer and the clinical trial host medical institution, characterized in that consisting of. 제 1 항에 있어서,The method of claim 1, 상기 수집된 임상시험 자원자 모집공고를 질병명과 진료과와 신체부위별과 지역별로 분류하여 임상시험 자원자 모집공고정보를 생성하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.The method for matching clinical trial information between the clinical trial volunteer and the clinical institution in charge of the clinical trial volunteer is characterized in that the clinical trial volunteer recruitment notification information is generated by classifying the collected clinical trial volunteer recruitment notification by disease name, medical department, body part and region. 제 1 항에 있어서,The method of claim 1, 상기 임상시험 주관의료기관으로부터 상기 적격 자원자 단말기로 요청되는 면접요청정보를 전송하는 단계를 더 포함하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.Method for matching clinical trial information between the clinical trial volunteer and the clinical trial host medical institution, characterized in that it further comprises the step of transmitting the interview request information requested from the clinical trial host medical institution to the qualified volunteer terminal. 제 1 항에 있어서,The method of claim 1, 상기 임상시험 주관의료기관으로부터 요청되는 추가 디지털 문진표를 생성하여 상기 적격 자원자 단말기로 제공하는 단계를 더 포함하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.Generating an additional digital questionnaire requested by the clinical trial host medical institution and providing to the eligible volunteer terminal terminal, clinical trial information matching method between the clinical trial volunteer and the clinical trial host medical institution. 제 4 항에 있어서,The method of claim 4, wherein 상기 추가 디지털 문진표는 주관식 설문을 포함하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.The additional digital questionnaire includes a subjective questionnaire, clinical trial information matching method between the clinical trial volunteer and the clinical trial host medical institution. 제 1 항에 있어서,The method of claim 1, 해외 임상시험정보 사이트에 외국어로 제공되는 국내 임상시험정보를 국어로 번역하여 제공하는 단계를 더 포함하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.The method for matching clinical trial information between a clinical trial volunteer and a clinical institution in charge of a clinical trial further comprising the step of translating the domestic clinical trial information provided in a foreign language into a foreign clinical trial information site. 제 1 항에 있어서,The method of claim 1, 상기 임상시험 자원자 문진표를 분석하여 특정기간 이내의 임상시험 중복 지원을 필터링하여 임상시험 대상자 적격 또는 부적격을 추가적으로 판단하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.The method for matching clinical trial information between the clinical trial volunteer and the clinical institution in charge of the clinical trial characterized in that the clinical trial volunteer questionnaire is analyzed to further filter the clinical trial overlap support within a specific period to further determine whether the trial candidate is eligible or ineligible. 제 1 항에 있어서,The method of claim 1, 상기 임상시험 주관의료기관으로부터 임상시험 주관의료기관정보 및 임상시험 자원자 모집공고정보를 전송받아 등록 및 관리하는 단계를 더 포함하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.The clinical trial information matching method between the clinical trial volunteer and the clinical trial host medical institution further comprising the step of receiving and registering the clinical trial subject medical institution information and clinical trial volunteer recruitment information from the clinical trial host medical institution. 제 1 항에 있어서,The method of claim 1, 상기 임상시험 주관의료기관에 의해 공고되지 않은 특정 임상시험에 대해서, 상기 임상시험 자원자 단말기로부터 상기 특정 임상시험에 대한 임상시험 자원자 정보를 선행적으로 수신하여 저장하고, 추후 상기 임상시험 주관의료기관으로부터 상기 특정 임상시험에 대한 임상시험 자원자 모집공고가 등록되면, 상기 임상시험 자원자 단말기로 상기 임상시험 자원자 모집공고 등록을 통보하고,Regarding a specific clinical trial not announced by the clinical trial supervisory medical institution, the clinical trial volunteer information for the specific clinical trial is preliminarily received and stored from the clinical trial volunteer terminal, and later, the specific clinical trial is managed by the clinical trial supervising medical institution. When the clinical trial volunteer recruitment notice for the clinical trial is registered, the clinical trial volunteer recruitment notification is notified to the clinical trial volunteer terminal, 상기 사전에 전송받은 임상시험 자원자 정보에는 상기 특정 임상시험 등록 알림의 유효기간 정보를 포함하며, 상기 유효기간 종료시점에 상기 특정 임상시험 등록 알림 유효기간 연장 여부를 상기 임상시험 자원자 단말기로 통보하고 이에 대해 해당 등록 알림을 중단하거나 연장하도록 하는 단계를 더 포함하는 것을 특징으로 하는 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 매칭 방법.The clinical trial volunteer information received in advance includes information on the validity period of the specific clinical trial registration notification, and at the end of the validity period, notify the clinical research volunteer terminal whether the specific clinical trial registration notification is extended. Stopping or extending the registration notification for the clinical trial information matching method between the clinical trial volunteer and the clinical trial host.
PCT/KR2017/012104 2017-04-11 2017-10-30 Method for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial Ceased WO2018190479A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20170046913 2017-04-11
KR10-2017-0046913 2017-04-11
KR1020170086257A KR20180133301A (en) 2017-04-11 2017-07-07 Method for Matching Clinical test information Between Volunteer and Medical Supervisor
KR10-2017-0086257 2017-07-07

Publications (1)

Publication Number Publication Date
WO2018190479A1 true WO2018190479A1 (en) 2018-10-18

Family

ID=63793264

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/012104 Ceased WO2018190479A1 (en) 2017-04-11 2017-10-30 Method for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial

Country Status (1)

Country Link
WO (1) WO2018190479A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110209107A (en) * 2019-05-10 2019-09-06 宁波安信数控技术有限公司 A kind of method and system by DTU remote debugging PLC device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099570A1 (en) * 2000-08-24 2002-07-25 Knight Stephen C. Recruiting a patient into a clinical trial
US20060149602A1 (en) * 2003-05-14 2006-07-06 Clinilabs, Inc. Methods and systems for online clinical trial screening
KR20100038623A (en) * 2008-10-06 2010-04-15 주식회사 더마프로 System and method of offering subject for clinical trials
JP2011233066A (en) * 2010-04-30 2011-11-17 Huma Corp Subject recruitment method, server of intermediary, software, and recording medium
US20140303999A1 (en) * 2011-11-07 2014-10-09 Mitchell D. Efros Method for creating and using registry of clinical trial participants

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099570A1 (en) * 2000-08-24 2002-07-25 Knight Stephen C. Recruiting a patient into a clinical trial
US20060149602A1 (en) * 2003-05-14 2006-07-06 Clinilabs, Inc. Methods and systems for online clinical trial screening
KR20100038623A (en) * 2008-10-06 2010-04-15 주식회사 더마프로 System and method of offering subject for clinical trials
JP2011233066A (en) * 2010-04-30 2011-11-17 Huma Corp Subject recruitment method, server of intermediary, software, and recording medium
US20140303999A1 (en) * 2011-11-07 2014-10-09 Mitchell D. Efros Method for creating and using registry of clinical trial participants

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110209107A (en) * 2019-05-10 2019-09-06 宁波安信数控技术有限公司 A kind of method and system by DTU remote debugging PLC device

Similar Documents

Publication Publication Date Title
Xavier et al. A needs assessment of transgendered people of color living in Washington, DC
KR20180133301A (en) Method for Matching Clinical test information Between Volunteer and Medical Supervisor
Barry et al. Community first responders for out‐of‐hospital cardiac arrest in adults and children
Whitbread et al. Recognition of ST elevation by paramedics
CN109935346A (en) A kind of intelligentized grass-roots community's health total management system
CN105956371A (en) Remote video interrogation system
WO2022145782A2 (en) Big data and cloud system-based artificial intelligence emergency medical care decision making and emergency patient transporting system and method therefor
CN108461135A (en) A kind of shared medical data analysis system and method
Considine et al. Emergency nurse practitioner care and emergency department patient flow: case–control study
KR102111063B1 (en) Method for diagnosing oral health status using internet and server thereof
Asazawa et al. Development of a partnership causal model for couples undergoing fertility treatment
Webel et al. The PROSPER-HIV study: a research protocol to examine relationships among physical activity, diet intake, and symptoms in adults living with HIV
Zaitoun et al. Audiology practice during COVID-19 crisis in Jordan and Arab countries
Nicholas et al. Engagement with care, substance use, and adherence to therapy in HIV/AIDS
Bachmann et al. The aging population: imperative to uncouple sex and gender to establish “gender equal” health care
Merz et al. Racism against healthcare users in inpatient care: a scoping review
Peerbhay et al. The use of tele-audiology in ototoxicity monitoring: A scoping review
Moroe et al. The impact of tinnitus on daily activities in adult tinnitus sufferers: A pilot study
Shah et al. Barriers and enablers to participating in regular screening programmes for women with cerebral palsy: A qualitative life course study
WO2018190479A1 (en) Method for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial
Haldar et al. A surveillance model for sexually transmitted infections in India
WO2018190480A1 (en) System for matching clinical trial information between clinical trial volunteers and medical institution conducting clinical trial
CN118571499A (en) Method, device and application for capturing keywords of critical illness data of potential donors in hospitals
Talashek et al. Sexually transmitted diseases in the elderly issues and recommendations
Bor et al. A testing time for doctors: counselling patients before an HIV test

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17905237

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17905237

Country of ref document: EP

Kind code of ref document: A1